Studies have also revealed that high expression of BCL11A may be associated with neuroblastoma [11], glioblastoma [85], laryngeal squamous cell carcinoma [86], ovarian cancer [24], and prostate cancer [23]. Here, BCL11A is linked to prostate carcinoma.